Earlier this month, Frederick celebrated Tonix Pharmaceuticals' new investment in a local state-of-the-art infectious disease research and development center. The acquisition of the 48,000 SF Frederick facility will support the company’s expanding pipeline of life-saving vaccines and antiviral therapeutics.
Learn more about the latest addition to Frederick’s booming life science industry in the press release below.